ESTRO 2024 - Abstract Book

S2485

Clinical - Urology

ESTRO 2024

Conclusion:

Despite the high prevalence of comorbidities, elderly and frail patients have excellent toxicity profiles and biochemical control. The reported results support the implementation of a personalized UHRT +/- ADT course as a valuable treatment option in this setting of patients.

Keywords: Elderly, Prostate, Comorbidities

2007

Proffered Paper

Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM)

Piet Ost 1,2 , Shankar Siva 3,4 , Sigmund Braband 5 , Piet Dirix 2 , Nick Liefhooghe 6 , François-Xavier Otte 7 , Alfonso Gomez iturriaga 8 , Wouter Everaerts 9,10 , Momhamed Shelan 11 , Antonio Conde-Moreno 12 , Fernando Lopez Campos 13 , Alexandros Papachristofilou 14 , Matthias Guckenberger 15 , Marta Scorsetti 16 , Almudena Zapatero 17 , Ana-Elena Villafranca Iturre 18 , Clara Eito 19 , Felipe Counago 20 , Paolo Muto 21 , Lien Van De Voorde 22 , Nicolas Mach 23 , Valérie Fonteyne 24 , Dries Reynders 25 , Thomas Zilli 26 , Daniel Moon 27